VB

Vishal Bhatt

Active Director Director DIN 08124896
DIN 08124896 First appointment May 2018 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2018
Shareholding value •••• Premium profile

About Vishal Bhatt

Data last updated:

Vishal Bhatt is a Director at Fuhrer Pharmaceuticals Private Limited (since 2018). The company operates in Chemicals. Fuhrer Pharmaceuticals Private Limited reported revenue of ₹43 Lakh (FY 2024).

DIN 08124896
Primary Designation Director
Industry Chemicals
First Appointment 03 May 2018
Oldest Company Age 8 yrs
Largest company Fuhrer Pharmaceuticals Private Limited · ₹43 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director03 May 20182018₹43 Lakh (FY 2024)Active

Board colleagues of Vishal Bhatt

NameDINCompanyDesignation
Sumit Kumar Chattoraj10705106Fuhrer Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Fuhrer Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Vishal Bhatt

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vishal Bhatt

Vishal Bhatt currently holds 1 directorship: Fuhrer Pharmaceuticals Private Limited (Director, since 03 May 2018, revenue ₹43 Lakh (FY 2024)).

Vishal Bhatt was first appointed on 03 May 2018 as Director at Fuhrer Pharmaceuticals Private Limited.

The current boards of Vishal Bhatt's companies include Sumit Kumar Chattoraj (Fuhrer Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available